Document Type : Letter to Editor

Author

Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Keywords

  1. Tjahjono HA, Barlianto W, Handayani D, Kalim H. Correlation between transforming growth factor-β1 (TGF- β1) with premature atherosclerosis in type 1 diabetes. ARYA Atheroscler. 2024;20(4):7-13. https://doi.org/10.48305/arya.2024.11581.2125
  2. Rochmah N, Triastuti IW, Deakandi WY, Irawan R, Faizi M, Endaryanto A. Decreased serum transforming growth factor-beta levels in Indonesian children with type 1 diabetes. J Med Pharm Chem Res 2024; 6(9):1478-84. https://doi.org/10.48309/ecc.2024.434749.1746
  3. Chen PY, Qin L, Simons M. TGFβ signaling pathways in human health and disease. Front Mol Biosci. 2023 Jun 1;10:1113061. https://doi.org/10.3389/fmolb.2023.1113061
  4. He C, Kim HI, Park J, Guo J, Huang W. The role of immune cells in different stages of atherosclerosis. Int J Med Sci. 2024 Apr 22;21(6):1129-43. https://doi.org/10.7150/ijms.94570
  5. Liuizė Abramavičiūtė A, Mongirdienė A. TGF-β Isoforms and GDF-15 in the Development and Progression of Atherosclerosis. Int J Mol Sci. 2024 Feb 9;25(4):2104. https://doi.org/10.3390/ijms25042104
  6. Chen PY, Qin L, Li G, Wang Z, Dahlman JE, Malagon-Lopez J, et al. Endothelial TGF-β signalling drives vascular inflammation and atherosclerosis. Nat Metab. 2019 Sep;1(9):912-26. https://doi.org/10.1038/s42255-019-0102-3